Deepak Iyer, Ms, Phd personal email
- Valid
From a young age, I've been captivated by the intricate world of life sciences. My academic journey led me to earn a Ph.D. in gastrointestinal cancer, where I developed a strong foundation in research and innovation. Through my work at various academic and commercial organizations, I’ve seen firsthand the transformative power of scientific advancements and the critical need to ensure these innovations reach the patients who need them most.Recently as a postdoctoral fellow, I was focused on identifying therapeutic targets for hematological cancers. This experience deepened my understanding of how research translates into practical applications that can improve patient care. I am particularly interested in how medical affairs and market access strategies can facilitate this translation, making cutting-edge therapies accessible to broader populations.I thrive on collaboration and believe that effective communication is key to bridging the gap between scientific research and healthcare delivery. I am excited about opportunities that allow me to contribute to impactful strategies that enhance patient access to innovative therapies, ultimately improving health outcomes.In my spare time, I enjoy experimenting with new recipes in the kitchen and exploring nature with my family, activities that fuel my creativity and keep me grounded.
-
Consultant AnalystShift HealthToronto, On, Ca
-
Postdoctoral FellowUniversity Health Network Jan 2022 - PresentToronto, Ontario, Canada- Led cross-functional research projects focused on innovative therapeutic strategies for drug-resistant multiple myeloma, resulting in the identification of key therapeutic targets that contributed to potential clinical applications. Key role in lab reorganization, grant writing, and training graduate students in vital lab skills for streamlined project management.- Secured a ~CAD 40,000 PMCore grant in Toronto, Canada, for a groundbreaking single-cell sequencing project, exemplifying excellence in research and project management. -
Strategic AdvisorIstemcare Jul 2020 - PresentUnited StatesIn 2020, iSTEMCare was founded with the vision of establishing a global and inclusive STEM (Science, Technology, Engineering, & Mathematics) community with a strong educational emphasis. The team behind iSTEMCare comprises a diverse group of STEM professionals, including students, research scientists, educators, communicators, illustrators, and industry experts from across the world. Together, we collaborate to curate a wide array of educational content, manage projects that provide valuable resources, mentorship, and guidance, all designed to enhance STEM career journeys on a global scale. -
Market Access Trainee - Metabolic Disorders (Diabetes)Life Sciences Career Development Syndicate (Lscds) Jan 2024 - May 2024Toronto, Ontario, CanadaSelected to partake in the competitive Industry Team Case Study (ITCS) program, focusing on the pharmaceutical Market Access sector, with professional mentorship provided by an industry expert.- Led a comprehensive budget impact analysis for a novel clinical agent undergoing review by Health Canada and CADTH in the diabetes domain, working closely with team members from the University of Toronto and a specialized market access consultant.- Played a key role within cross-functional teams to compellingly articulate the unmet needs and value proposition of pharmaceutical products in Canadian markets, showcasing adept consulting skills.- Conducted meticulous scrutiny of clinical trial data and CADTH resources to precisely forecast drug reimbursement potential and accurately estimate market size. -
Business Fundamentals TraineeGraduate Management Consulting Association (Gmca) Jan 2024 - Apr 2024Participated in an exclusive, highly competitive mini-MBA certificate program hosted by the GMCA at the University of Toronto, tailored explicitly for the business consulting field. This rigorous program comprises of 10 weekly lectures covering a wide spectrum of topics, including Finance, Marketing, Entrepreneurship, Economics, Data Science, and Patents and IP Law. Each session is led by seasoned industry professionals hailing from renowned consulting firms or top business schools.- Gained a comprehensive understanding of fundamental business principles crucial to both the pharmaceutical and consulting sectors, with a specific focus on innovative strategies and commercialization techniques.- Engaged in a collaborative team-based case study challenge designed to hone problem-solving skills and enhance communication abilities. -
Postdoctoral ScientistArbele Feb 2021 - Mar 2023Hong Kong Sar- Spearheaded the development of a class 3 IVD for companion immunodiagnostics, expediting the clinical advancement of an immunotherapeutic. Secured a patent (WO2023060276) for innovative Cadherin-17 protein detection techniques, enhancing early gastrointestinal cancer identification.- Managed a remote advisory role (~15 months) from Canada, overseeing a collaborative team in Hong Kong for a ~HKD 1million Public Sector Trial Scheme – ITF project. Conducted a pre-clinical trial for specific Cadherin-17 protein detection, resulting in selection for a poster presentation at ASCO 2023.- Leveraged project management expertise to drive the creation of marketing videos and website development, while strategically guiding business development initiatives to accelerate organizational growth. -
Research Assistant (I)The University Of Hong Kong Oct 2018 - Feb 2021Hong Kong- Investigated the potential role of PIWI-interacting RNAs (piRNAs) in colorectal cancer, leading a systematic discovery and validation experiment that unveiled the first comprehensive profile of piRNAs in this context. This research highlighted piR-24000 as a potential oncogenic piRNA associated with aggressive colorectal cancer, leading to a significant research publication.- Explored miR-187-3p as a novel tumor suppressor in colorectal cancer through functional experiments aimed at understanding its impact on the disease by targeting SPRY1. This investigation resulted in a noteworthy publication.- Secured a prestigious ~HKD 1 million Hong Kong Medical Research funding (HMRF) for a biomarker-based translational research project for our group, uncovering the unique role of the tumor microenvironment in disease prognosis.- Led and actively collaborated on multiple projects, resulting in over 10 publications in esteemed international journals, while also mentoring and training students and interns in molecular and cell biology techniques to foster a highly productive lab team. -
Phd StudentUniversity Of Hong Kong Jan 2014 - Dec 2018Hong Kongo Dysregulation of tissue microRNAs in colorectal cancer and their potential role as prognostic and predictive biomarkers Aimed towards the investigation of predictive, prognostic small non-coding RNAs in colorectal cancer to gain a specific and sensitive evaluation of the overall course of the disease to allow improved disease management. Key Results: (1) A novel tissue microRNA (miR-509-3p) was identified in colorectal cancer that was found to induce tumor cell proliferation, survival and development of metastasis in vitro and in vivo. (2) Expression of miR-509-3p was found to be significantly increased in primary tumor-adjacent normal tissues of colorectal cancer patients showing future recurrences/cancer progression while correlating with their 5-year survival and disease-free survival parameters. (3) miR-509-3p was found to promote lateral oncogenesis including cell proliferation, survival, and development of metastasis in vitro which was shown by indirect co-culture experiments. Functional techniques involved: Small RNA sequencing and data analysis, qPCR, molecular cloning, western blotting, functional assays including, cell proliferation, survival, migration, invasion, and co-culture assays as well as development and study of in vivo (mouse) tumor models.
-
Senior Research Fellow - Dr. Amit Dutt LabAdvanced Centre For Treatment, Research And Education In Cancer(Actrec) Jun 2013 - Dec 2013Kharghar, India- Drug-sensitive FGFR3 mutations in lung adenocarcinoma Characterized the functional relevance of activated oncogenic FGFR tyrosine kinase that could represent genetic vulnerabilities, and potential targets for new therapies in lung cancer. My contributions to the project resulted in a notable publication in Annals of Oncology. Functional techniques involved: Retroviral transfection, Soft agar oncogenic assays, MTT based drug assays, Western blotting, in addition to molecular lab approaches such as cloning & site-directed mutagenesis. -
Project CoordinatorSaflabs Pvt. Ltd. Jan 2011 - May 2013Mumbai Area, India- Proficient in DNA construct cloning and subcloning using both conventional TA/restriction enzyme-based methods and cutting-edge patented techniques like Gateway cloning (Invitrogen).- Demonstrated technical prowess in a range of molecular biology processes, including the isolation and purification of nucleic acids (genomic DNA, RNA, plasmid), and Sanger sequencing.- Provided expert technical support to customers, guiding them through molecular workflows within genomic and proteomic project pathways.- Leveraged strong business development skills to oversee the hiring and training of research scientists and assume comprehensive management responsibilities for the molecular biology services division of the organization.- Orchestrated end-to-end company operations, encompassing laboratory setup, customer acquisition, project management, negotiations, and ensuring successful project delivery. -
Product SpecialistPreventine Life Care Pvt. Ltd. Apr 2009 - Feb 2010Mumbai Area, India- Engaged in disease research focused on inborn errors of metabolism through GC/MS-based newborn screening.- Effectively managed projects related to newborn screening and provided technical support to clinicians and prospective parents, underscoring the critical role of this research in disease prevention.
Deepak Iyer, Ms, Phd Skills
Deepak Iyer, Ms, Phd Education Details
-
Translational Research In Gi Cancers
-
Molecular Medicine And Cancer Research -
Biomedical Sciences -
Jamnaben Hirachand Ambani SchoolHigh School
Frequently Asked Questions about Deepak Iyer, Ms, Phd
What company does Deepak Iyer, Ms, Phd work for?
Deepak Iyer, Ms, Phd works for Shift Health
What is Deepak Iyer, Ms, Phd's role at the current company?
Deepak Iyer, Ms, Phd's current role is Consultant Analyst.
What is Deepak Iyer, Ms, Phd's email address?
Deepak Iyer, Ms, Phd's email address is de****@****ail.com
What schools did Deepak Iyer, Ms, Phd attend?
Deepak Iyer, Ms, Phd attended The University Of Hong Kong, Brunel University Of London, University Of Central Lancashire, Jamnaben Hirachand Ambani School.
What skills is Deepak Iyer, Ms, Phd known for?
Deepak Iyer, Ms, Phd has skills like Lifesciences, Molecular Biology, Pcr, Biotechnology, Elisa, Dna, Genetics, Genomics, Molecular Cloning, Cell, Western Blotting, Tissue Culture.
Who are Deepak Iyer, Ms, Phd's colleagues?
Deepak Iyer, Ms, Phd's colleagues are Jonsson Liu, Youssef Hayek, Francesca Talley, Nicole Revie, Phd, Zoya Adeel, Soo-Jin An, Tracy Tan.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial